Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease

Yayoi Matsumura-Kimoto, Yoshihiro Inamoto, Kinuko Tajima, Akihisa Kawajiri, Takashi Tanaka, Tsuneaki Hirakawa, Kazuko Ino, Yu Asao, Hiroyuki Tamogami, Chika Kono, Wataru Takeda, Keiji Okinaka, Shigeo Fuji, Saiko Kurosawa, Sung Won Kim, Ryuji Tanosaki, Takuya Yamashita, Takahiro Fukuda

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

This study aimed to characterize the incidence and risk factors of invasive fungal disease, cytomegalovirus infection, other viral diseases, and gram-negative rod infection after glucocorticoid treatment for severe acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation and to elucidate the associations of cumulative steroid dose with the risks of individual infections. The study cohort included 91 consecutive patients who developed maximum grades III and IV acute GVHD at our center. The mean cumulative prednisolone-equivalent dose was 41 mg/kg during the first 4 weeks. The cumulative incidence rates of fungal disease, cytomegalovirus disease, other viral diseases, and gram-negative rod infection at 6 months after glucocorticoid treatment were remarkably high, at 14%, 21%, 28%, and 20%, respectively. GVHD within 26 days after transplantation and low lymphocyte count at GVHD treatment were associated with increased risks of several infections. Cumulative prednisolone-equivalent steroid doses ≥ 55 mg/kg during the first 4 weeks were associated with an increased risk of fungal disease (hazard ratio, 3.65; P = .03) and cumulative doses ≥ 23 mg/kg were associated with an increased risk of non-cytomegalovirus viral diseases (hazard ratio, 4.14; P = .02). Strategies to reduce the risk of infectious complications are needed, particularly for patients who have risk factors and those who receive high cumulative steroid doses.

Original languageEnglish
Pages (from-to)1102-1107
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume22
Issue number6
DOIs
Publication statusPublished - 2016 Jun 1
Externally publishedYes

Fingerprint

Graft vs Host Disease
Steroids
Mycoses
Virus Diseases
Infection
Prednisolone
Glucocorticoids
Therapeutics
Incidence
Cell Transplantation
Cytomegalovirus Infections
Lymphocyte Count
Cytomegalovirus
Cohort Studies
Transplantation

Keywords

  • Adenovirus
  • Cytomegalovirus
  • Fungal infection
  • Graft-versus-host disease
  • Hematopoietic cell transplantation
  • Steroid dose

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease. / Matsumura-Kimoto, Yayoi; Inamoto, Yoshihiro; Tajima, Kinuko; Kawajiri, Akihisa; Tanaka, Takashi; Hirakawa, Tsuneaki; Ino, Kazuko; Asao, Yu; Tamogami, Hiroyuki; Kono, Chika; Takeda, Wataru; Okinaka, Keiji; Fuji, Shigeo; Kurosawa, Saiko; Kim, Sung Won; Tanosaki, Ryuji; Yamashita, Takuya; Fukuda, Takahiro.

In: Biology of Blood and Marrow Transplantation, Vol. 22, No. 6, 01.06.2016, p. 1102-1107.

Research output: Contribution to journalArticle

Matsumura-Kimoto, Y, Inamoto, Y, Tajima, K, Kawajiri, A, Tanaka, T, Hirakawa, T, Ino, K, Asao, Y, Tamogami, H, Kono, C, Takeda, W, Okinaka, K, Fuji, S, Kurosawa, S, Kim, SW, Tanosaki, R, Yamashita, T & Fukuda, T 2016, 'Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease', Biology of Blood and Marrow Transplantation, vol. 22, no. 6, pp. 1102-1107. https://doi.org/10.1016/j.bbmt.2016.02.020
Matsumura-Kimoto, Yayoi ; Inamoto, Yoshihiro ; Tajima, Kinuko ; Kawajiri, Akihisa ; Tanaka, Takashi ; Hirakawa, Tsuneaki ; Ino, Kazuko ; Asao, Yu ; Tamogami, Hiroyuki ; Kono, Chika ; Takeda, Wataru ; Okinaka, Keiji ; Fuji, Shigeo ; Kurosawa, Saiko ; Kim, Sung Won ; Tanosaki, Ryuji ; Yamashita, Takuya ; Fukuda, Takahiro. / Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease. In: Biology of Blood and Marrow Transplantation. 2016 ; Vol. 22, No. 6. pp. 1102-1107.
@article{dafb09dac9ee4b569ea9653b471ac20f,
title = "Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease",
abstract = "This study aimed to characterize the incidence and risk factors of invasive fungal disease, cytomegalovirus infection, other viral diseases, and gram-negative rod infection after glucocorticoid treatment for severe acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation and to elucidate the associations of cumulative steroid dose with the risks of individual infections. The study cohort included 91 consecutive patients who developed maximum grades III and IV acute GVHD at our center. The mean cumulative prednisolone-equivalent dose was 41 mg/kg during the first 4 weeks. The cumulative incidence rates of fungal disease, cytomegalovirus disease, other viral diseases, and gram-negative rod infection at 6 months after glucocorticoid treatment were remarkably high, at 14{\%}, 21{\%}, 28{\%}, and 20{\%}, respectively. GVHD within 26 days after transplantation and low lymphocyte count at GVHD treatment were associated with increased risks of several infections. Cumulative prednisolone-equivalent steroid doses ≥ 55 mg/kg during the first 4 weeks were associated with an increased risk of fungal disease (hazard ratio, 3.65; P = .03) and cumulative doses ≥ 23 mg/kg were associated with an increased risk of non-cytomegalovirus viral diseases (hazard ratio, 4.14; P = .02). Strategies to reduce the risk of infectious complications are needed, particularly for patients who have risk factors and those who receive high cumulative steroid doses.",
keywords = "Adenovirus, Cytomegalovirus, Fungal infection, Graft-versus-host disease, Hematopoietic cell transplantation, Steroid dose",
author = "Yayoi Matsumura-Kimoto and Yoshihiro Inamoto and Kinuko Tajima and Akihisa Kawajiri and Takashi Tanaka and Tsuneaki Hirakawa and Kazuko Ino and Yu Asao and Hiroyuki Tamogami and Chika Kono and Wataru Takeda and Keiji Okinaka and Shigeo Fuji and Saiko Kurosawa and Kim, {Sung Won} and Ryuji Tanosaki and Takuya Yamashita and Takahiro Fukuda",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.bbmt.2016.02.020",
language = "English",
volume = "22",
pages = "1102--1107",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease

AU - Matsumura-Kimoto, Yayoi

AU - Inamoto, Yoshihiro

AU - Tajima, Kinuko

AU - Kawajiri, Akihisa

AU - Tanaka, Takashi

AU - Hirakawa, Tsuneaki

AU - Ino, Kazuko

AU - Asao, Yu

AU - Tamogami, Hiroyuki

AU - Kono, Chika

AU - Takeda, Wataru

AU - Okinaka, Keiji

AU - Fuji, Shigeo

AU - Kurosawa, Saiko

AU - Kim, Sung Won

AU - Tanosaki, Ryuji

AU - Yamashita, Takuya

AU - Fukuda, Takahiro

PY - 2016/6/1

Y1 - 2016/6/1

N2 - This study aimed to characterize the incidence and risk factors of invasive fungal disease, cytomegalovirus infection, other viral diseases, and gram-negative rod infection after glucocorticoid treatment for severe acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation and to elucidate the associations of cumulative steroid dose with the risks of individual infections. The study cohort included 91 consecutive patients who developed maximum grades III and IV acute GVHD at our center. The mean cumulative prednisolone-equivalent dose was 41 mg/kg during the first 4 weeks. The cumulative incidence rates of fungal disease, cytomegalovirus disease, other viral diseases, and gram-negative rod infection at 6 months after glucocorticoid treatment were remarkably high, at 14%, 21%, 28%, and 20%, respectively. GVHD within 26 days after transplantation and low lymphocyte count at GVHD treatment were associated with increased risks of several infections. Cumulative prednisolone-equivalent steroid doses ≥ 55 mg/kg during the first 4 weeks were associated with an increased risk of fungal disease (hazard ratio, 3.65; P = .03) and cumulative doses ≥ 23 mg/kg were associated with an increased risk of non-cytomegalovirus viral diseases (hazard ratio, 4.14; P = .02). Strategies to reduce the risk of infectious complications are needed, particularly for patients who have risk factors and those who receive high cumulative steroid doses.

AB - This study aimed to characterize the incidence and risk factors of invasive fungal disease, cytomegalovirus infection, other viral diseases, and gram-negative rod infection after glucocorticoid treatment for severe acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation and to elucidate the associations of cumulative steroid dose with the risks of individual infections. The study cohort included 91 consecutive patients who developed maximum grades III and IV acute GVHD at our center. The mean cumulative prednisolone-equivalent dose was 41 mg/kg during the first 4 weeks. The cumulative incidence rates of fungal disease, cytomegalovirus disease, other viral diseases, and gram-negative rod infection at 6 months after glucocorticoid treatment were remarkably high, at 14%, 21%, 28%, and 20%, respectively. GVHD within 26 days after transplantation and low lymphocyte count at GVHD treatment were associated with increased risks of several infections. Cumulative prednisolone-equivalent steroid doses ≥ 55 mg/kg during the first 4 weeks were associated with an increased risk of fungal disease (hazard ratio, 3.65; P = .03) and cumulative doses ≥ 23 mg/kg were associated with an increased risk of non-cytomegalovirus viral diseases (hazard ratio, 4.14; P = .02). Strategies to reduce the risk of infectious complications are needed, particularly for patients who have risk factors and those who receive high cumulative steroid doses.

KW - Adenovirus

KW - Cytomegalovirus

KW - Fungal infection

KW - Graft-versus-host disease

KW - Hematopoietic cell transplantation

KW - Steroid dose

UR - http://www.scopus.com/inward/record.url?scp=84962559856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962559856&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2016.02.020

DO - 10.1016/j.bbmt.2016.02.020

M3 - Article

C2 - 26968790

AN - SCOPUS:84962559856

VL - 22

SP - 1102

EP - 1107

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -